Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines
ACS Nano · 12.08.2025 · 19 (31) · 28295-28314
DOI: 10.1021/acsnano.5c06081 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 01.08.2025. Verfasst von Jeswin Joseph und 16 weiteren Autor:innen. Beteiligte Einrichtung: Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananth…. Hauptthemen laut MEDLINE: Nanoparticles, COVID-19 Vaccines, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 126 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, University Grants Commission, Science and Engineering Research Board.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram 695551, India.
- Immuno-biology Laboratory, Translational Health Science & Technology Institute (THSTI), Faridabad 121001, India.
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram 695551, India.
- Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute (THSTI), Faridabad 121001, India.
- Central Animal Facility, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram 695551, India.
ORCID-Profile: Jeswin Joseph, Kavitha Modenkattil Sethumadhavan, Reji Varghese, V Stalin Raj
Förderung
- Council of Scientific and Industrial Research, India
- University Grants Commission
- Science and Engineering Research Board
- Department of Science and Technology, Ministry of Science and Technology, India
- Ministry of Education, India
- Indian Institute of Science Education and Research Thiruvananthapuram
- Anusandhan National Research Foundation (ANRF), (ERSTWHILE SERB), New Delhi, India
Zitieren
APA
Joseph, J., Modenkattil Sethumadhavan, K., Ahlawat, P., Prakash, M., Kandpal, G., Raj, G., Srivastava, H., Charulekha, P., K Dev, A., Radhakrishnan, A., Singh, V., Yadav, R., Chandramohanan, P., Varghese, R., Rizvi, Z. A., Awasthi, A., & Raj, V. S. (2025). Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines. ACS Nano, 19(31), 28295-28314. https://doi.org/10.1021/acsnano.5c06081
Vancouver
Joseph J, Modenkattil Sethumadhavan K, Ahlawat P, Prakash M, Kandpal G, Raj G, et al. Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines. ACS Nano. 2025;19(31):28295-28314. doi:10.1021/acsnano.5c06081
BibTeX
@article{Joseph2025,
author = {Joseph, Jeswin and Modenkattil Sethumadhavan, Kavitha and Ahlawat, Priyanca and Prakash, Malavika and Kandpal, Gayatri and Raj, Gowtham and Srivastava, Harshal and Charulekha, Packirisamy and K Dev, Aswin and Radhakrishnan, Akshaya and Singh, Virendra and Yadav, Rahul and Chandramohanan, Purnima and Varghese, Reji and Rizvi, Zaigham Abbas and Awasthi, Amit and Raj, V Stalin},
title = {Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {31},
pages = {28295--28314},
doi = {10.1021/acsnano.5c06081}
}
EUVIMED